ArticleAmerican journal of cancer research2025

Overexpression of SHANK2 contributes malignant outcomes as a Hippo pathway regulator in gastric cancer.

Hiroshi Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.